A Phase 2a, Randomized, Double-blind, Placebo- and Naproxen Controlled, Parallel-group Study to Assess the Analgesic Efficacy of ASP7962 in Patients With Pain Due to Osteoarthritis of the Knee

Trial Profile

A Phase 2a, Randomized, Double-blind, Placebo- and Naproxen Controlled, Parallel-group Study to Assess the Analgesic Efficacy of ASP7962 in Patients With Pain Due to Osteoarthritis of the Knee

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Oct 2017

At a glance

  • Drugs ASP 7962 (Primary) ; Naproxen
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Acronyms OAK
  • Sponsors Astellas Pharma Europe Ltd
  • Most Recent Events

    • 11 Oct 2017 Status changed from active, no longer recruiting to completed.
    • 27 Jul 2017 Status changed from recruiting to active, no longer recruiting.
    • 27 Feb 2017 Planned End Date changed from 1 Jun 2017 to 1 Sep 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top